Search This Blog

Thursday, May 7, 2026

BioLife beats, reaffirms guidance

 

BioLife Solutions beats Q1 2026 EPS and revenue estimates with non-GAAP EPS $0.02, revenue $27.5M, reiterates 2026 guidance

  • Non-GAAP EPS $0.02 increased 300% YoY in Q1 2026, exceeding analyst estimates.
  • Q1 2026 revenue was $27.5M, up 15% YoY, also above revenue estimates.
  • GAAP EPS for Q1 2026 was $0.02, and the company reiterated full-year 2026 financial guidance.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)